A prospective study to evaluate the effectiveness of polyherbal formulation containing Terminalia arjuna and Terminalia chebula on cardiovascular events in patients with pre-existing heart disease.

This study is being conducted to check the usefulness and safety of a herbal formulation called Cardio Pro (made from Terminalia arjuna and Terminalia chebula) in people who already have heart disease. All participants will continue their usual standard treatment. In addition, some participants will also receive Cardio Pro. The aim is to see whether Cardio Pro can help improve heart health, reduce risk factors, and support recovery without causing major side effects. Participation is voluntary, and all personal details will be kept confidential. Compensation will be given for travel and time.